Building scale and momentum with commercially-led growth
IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, will hold its Annual General Meeting at 9.30am today at the offices of FTI Consulting LLP, 200 Aldersgate, London, EC1A 4HD.
At the meeting Charles Spicer, the Company’s Chairman will make the following statement:
”The year ended 30 September 2017 was a year of change for the Company, with a renewed focus on our biopharmaceutical customers. I am pleased to report a strong performance with increased revenue and reduced operating losses.